Rimsa

Investors Count

Deal Terms

Funding, Valuation & Revenue

1 Fundings

Rimsa's latest funding round was a Acquired for on October 1, 2015.

Rimsa's latest post-money valuation is from October 2015.

Date	Round	Amount	Investors	Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.	Revenue	Sources
10/1/2015	Acquired		Teva	$XXM	0 FY undefined	3

Date	10/1/2015
Round	Acquired
Amount
Investors	Teva
Valuation	$XXM
Revenue	0 FY undefined
Sources	3

Rimsa Deal Terms

1 Deal Term

Rimsa's deal structure is available for 1 funding round, including their Acquired from October 01, 2015.

Round	Acquired
Funding Date	$XXM
Pre-Money Valuation
Post-Money Valuation	$XXM
Amount Raised
Shares Authorized
Issuance Price
Dividend Rate
Liquidation Preferences
Liquidation Price
Participation
Conversion Price
Anti Dilution
General Voting	$XXM
Board Voting	$XXM
Par Value

Round	Funding Date	Pre-Money Valuation	Post-Money Valuation	Amount Raised	Shares Authorized	Issuance Price	Dividend Rate	Liquidation Preferences	Liquidation Price	Participation	Conversion Price	Anti Dilution	General Voting	Board Voting	Par Value
Acquired	$XXM		$XXM										$XXM	$XXM

Rimsa Investors

1 Investors

Rimsa has 1 investors. Teva invested in Rimsa's Acquired funding round.

First funding	Last Funding	Investor	Rounds	Board Seats	Type	Location
10/1/2015	10/1/2015	Teva	1 Acquired		Corporation	Israel

First funding	10/1/2015
Last Funding	10/1/2015
Investor	Teva
Rounds	1 Acquired
Board Seats
Type	Corporation
Location	Israel

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.

How VCs Use CB Insights

Professional Services